Industry reports
Editor highlights

Cancer Immunotherapy Market and Forecasts, April 2014

You might be interested in: ovarian cancer, stem cell, vaccine, more »


 
1-10 of 24 reports for Cancer Immunotherapy

Prostate Cancer Sector (prostate cancer, colorectal cancer, smallpox) in The United States and Canada

  • Industry report
  • January 2014
  • 34 pages

... Cadence pharmaceuticals, lilly, serono) as president of cancer immunotherapy division and executive vice president 4 recent highlights 5 pipeline infectious diseases preclinical phase 1 phase 1 ...

Cancer Market in The United States, Australia and Canada

  • Industry report
  • January 2012
  • 13 pages

... To attack cancer cells and halt their out-of-control growth, as it has been shown to do with melanoma. - Rogress_in_cancer_immunotherapy ...

Biomarker and Genome Sequencing Sectors Brief

  • Industry report
  • October 2013
  • 4 pages
  • by Corporation

... immunotherapies dr. Cedrik britten, group leader cell-mediated immunity, tron ggmbh marketplace personalized medicine technologies programm tuesday, 08.10.2013 Next generation sequencing moderator: peter pohl, bio ...

U.S. Pharmaceutical Business

  • Industry report
  • March 2013
  • 26 pages

... Nktr-181 chronic pain nktr-192 acute pain nktr-171 neuropathic pain nktr-214 cancer immunotherapy high-value market opportunities key financial achievements monetized selected non ...

Autoimmune Disease Sector (autoimmune disease, cancer, musculoskeletal disorder) in The United States

  • Industry report
  • January 2012
  • 28 pages

... The date of this presentation. 2 Coronado biosciences Two biologic product cands in clinical stage development - focused on autoimmune diseases and cancer immunotherapy - strong proprietary ...

Global Chronic Pain Market Overview (chronic pain, breast cancer)

  • Industry report
  • June 2013
  • 27 pages

... Chronic pain) nktr-102 (colorectal cancer) nktr-192 (acute pain) nktr-119 (naloxegol + opioid) p r e c lin ic a l nktr-171 (neuropathic pain) nktr-214 (cancer immunotherapy) nktr-223 ...

World Chronic Pain Industry Overview (chronic pain, breast cancer, constipation)

  • Industry report
  • May 2013
  • 24 pages

... Preclinical nktr-171 (neuropathic pain) nktr-214 (cancer immunotherapy) nktr-223 (peptide antibiotic) nktr-228 (secondary hyperparathyroidism) resear c h nktr-195 (visceral pain) nktr-174 (nociceptive pain ...

World Chronic Pain Industry Overview (chronic pain, breast cancer)

  • Industry report
  • June 2013
  • 27 pages
  • by Corporation

... Chronic pain) nktr-102 (colorectal cancer) nktr-192 (acute pain) nktr-119 (naloxegol + opioid) p r e c lin ic a l nktr-171 (neuropathic pain) nktr-214 (cancer immunotherapy) nktr-223 ...

Pharmaceutical Market in The United States

  • Industry report
  • July 2012
  • 40 pages

... Convention | april 22 - 25, 2013 - chicago | - cancer immunotherapy consortium, entering the era of combination therapies: practical implementation | april 25 - 27, 2013 ...

Clinical Study Production and Trade Statistics in Japan and China

  • Industry report
  • November 2013
  • 46 pages

... Office operation for clinical trial hospital support service histopathological diagnosis gene expression analysis biomarker measurement reagent sales for cancer immunotherapy ...

» Purchase Premium Reports (From $ 250 - $ 11 400)

39 reports for Cancer Immunotherapy
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

The androgen receptor signaling pathway activates the SMAD signaling module. There are today 327 companies plus partners developing 426 Androgen Receptor drugs in 1397 developmental projects in cancer. ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.